On June 13, 2025, Dave & Buster’s Entertainment, Inc. (the “Company”) announced the retirement of John Mulleady, Chief Development Officer and a named executive officer.
On June 13, 2025, NextDecade Corporation (the “Company”) received a letter from Mr. Timothy Wyatt indicating that he was resigning from the Company's Board of Directors (the “Board”), effective immediately.
On June 10, 2025, SRx Health Solutions, Inc. (the “ Company ”) accepted the voluntary resignation of Davender Sohi as the President of the Company, effective immediately.
On June 13, 2025, Imunon, Inc. (the “Company”) terminated the consulting agreement (as amended, the “Agreement”), dated April 15, 2024, by and between the Company and Monomoy Advisors, LLC, a financial advisory services firm (“Monomoy”), as well as David Gaiero’s service pursuant to the Agreement as the Company’s interim Chief Financial Officer (a position he has held since June of 2024), in each case effective June 13, 2025.
On June 9, 2025, Zscaler, Inc. (the “Company”) entered into a Transition Agreement and Release (the “Transition Agreement”) with Remo Canessa, in connection with his previously disclosed retirement.
Departed
Jelena Olmstead
Chief Executive Officer and Director
Healthtech Solutions, Inc./UT
Effective
2025-06-06
Successor
James Pesoli
Filed
June 13, 2025, 7:59 PM ET
Jelena Olmstead, who served as chief executive officer and a director of the Company, resigned as a director, officer and employee of the Company and HTWC.
Departed
Karla C. Robertson
Executive Vice President, CSO, General Counsel and Secretary
On June 12, 2025, Interface, Inc. (the “Company”) and Nigel Stansfield, the Company’s Chief Innovation & Sustainability Officer, announced that the Company will eliminate the position of Chief Innovation & Sustainability Officer held by Mr. Stansfield later this year.
On June 6, 2025, Bilal Muhsin, Chief Operating Officer, informed the Company he was resigning to pursue other opportunities, effective July 1, 2025.
Departed
Charles Riceman
Co-President
Varagon Capital Corp
Effective
2025-06-06
Filed
June 12, 2025, 7:59 PM ET
On June 6, 2025, Charles Riceman and Varagon Capital Corporation (the “Company”) agreed that Mr. Riceman will retire from his position as Co-President of the Company, effective immediately.
On June 12, 2025, Onto Innovation, Inc. (the “Company” or “Onto Innovation”) and Mr. Mark Slicer, the Company’s Chief Financial Officer (“CFO”), agreed to mutually terminate Mr. Slicer’s employment with the Company, effective immediately.
On June 10, 2025, Thomas F. Frist, III submitted his resignation to the Board of Directors of VeriSign, Inc. (the "Company"), citing other personal and professional time commitments.
Ting (Tim) Xiao did not stand for re-election at the expiration of his term ending at the Annual Meeting, and, accordingly, as of the conclusion of the Annual Meeting Mr. Xiao’s term ended with his resignation from the Board of Directors of the Company
Departed
Richard Geary
executive vice president and chief development officer
On June 12, 2025, Ionis Pharmaceuticals, Inc. (the “ Company ”) issued a press release announcing that Richard Geary Ph.D., executive vice president and chief development officer, will retire effective January 2026.
On June 2, 2025, William A. Longbrake, a member of the Board of Directors (the “Board”) of Broadway Financial Corporation (the “Company”) (NASDAQ: BYFC), notified the Board that he is resigning as a director of the Company at the Company’s 2025 Annual Meeting of Stockholders on June 30, 2025.
On June 11, 2025, Ms. Laura Cooper resigned as a director of Auburn National Bancorporation, Inc. (the “Company”) and the Company’s wholly owned subsidiary, AuburnBank (the “Bank”).
the Company announced that effective June 7, 2025, Mr. David Mansfield, age 65, has departed and is no longer serving as the Chief Executive Officer.
Departed
Charles Guan
Director
Jamf Holding Corp.
Effective
2025-06-10
Filed
June 12, 2025, 7:59 PM ET
Charles Guan and Virginia Gambale will no longer serve as members of the Company's Board of Directors (the "Board"), effective following the Annual Meeting.
Departed
Virginia Gambale
Director
Jamf Holding Corp.
Effective
2025-06-10
Filed
June 12, 2025, 7:59 PM ET
Charles Guan and Virginia Gambale will no longer serve as members of the Company's Board of Directors (the "Board"), effective following the Annual Meeting.
On June 12, 2025, the Board of Directors of SEATECH VENTURES CORP. (the “Company”) accepted the resignation of CHIN CHEE SEONG, as the Company’s Chairperson of the Board of Directors, Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary, and Director.
On June 5, 2025, Usanee Lekvanichkul submitted her resignation, effective as of June 6, 2025, from her positions as Chief Financial Officer and Executive Director of Kairous Acquisition Corp. Limited (the “Company”).
On June 9, 2025, Keith Rabois, a member of the Board of Directors (the “Board”) of Affirm Holdings, Inc. (the “Company”), resigned as a member of the Board, effective June 30, 2025.
the Original Form 8-K reported that, on April 28, 2025, Stephen Lovass ceased to serve as segment leader for the Medical and Fluid Solutions Segment of Nordson Corporation
Departed
Dan Hines
Senior Vice President, Corporate Controller and Principal Accounting Officer
On June 10, 2025, the Company announced that on June 30 Dan Hines will retire as Senior Vice President, Corporate Controller, and Principal Accounting Officer.
Effective as of June 30, 2025, Ms. Young will cease to serve as Chief Operating Officer, Experiential Services, and will continue with the Company as a non-executive employee assisting on certain projects.
Mr. Thakral will replace Peter M. Neupert, who has served as Interim Chief Executive Officer since May 13, 2025, although Mr. Neupert will continue to serve as a director of the Company and Chairman of the Board.
Victor Nesi, Co-President and Institutional Group Head, of his retirement from the Company effective on July 1, 2025.
Departed
Jeremy White
Chief Executive Officer
Veritas Farms, Inc.
Effective
2025-06-21
Successor
Thomas E. Vickers
Filed
June 11, 2025, 7:59 PM ET
Jeremy White ("Mr. White") notified the Chairman of the Board of Directors of the Company that he would be stepping down as Chief Executive Officer of the Company effective June 21, 2025.
Departed
David J. Loundy
Board of Directors
Federal Home Loan Bank of Chicago
Effective
2025-06-05
Filed
June 11, 2025, 7:59 PM ET
On June 5, 2025, the Federal Home Loan Bank of Chicago (the “Bank”) received notification from David J. Loundy that he is resigning from the Bank’s Board of Directors (the “Board”), effective on that same date.
Departed
Todd McNabb
Chief Revenue Officer
PROS Holdings, Inc.
Effective
2025-07-01
Filed
June 11, 2025, 7:59 PM ET
On June 10, 2025, PROS Holdings, Inc. (the “Company”) and Todd McNabb, the Company’s Chief Revenue Officer, mutually agreed that Mr. McNabb would cease serving as the Company’s Chief Revenue Officer, effective July 1, 2025, and that Mr. McNabb would remain with the Company through July 19, 2025.
On June 5, 2025, the Board of Directors (the “ Board ”) of Allarity Therapeutics, Inc. (the “ Company ”) received the resignation of Joseph W. Vazzano as director of the Company, effective June 30, 2025.
Also on June 11, 2025, the Company announced that Michael Schwindle, the Company’s Chief Financial Officer (“CFO”), will be stepping down from his position as CFO, effective June 12, 2025.
On June 11, 2025, Vera Bradley, Inc. (the "Company") announced that Jackie Ardrey has decided to step down from her position as President and Chief Executive Officer (“CEO”) of the Company.
Mr. Yoram Baumann, Chairman of the Board of Directors of Viewbix Inc. (the “Board” and the “Company”, respectively), tendered his resignation from the Board, effective immediately.
On June 9, 2025, Andrew Ritter resigned as a member of the board of directors (the “Board”) of the Company and all committees thereof.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.